Hypertension and coronary artery ectasia: a systematic review and meta-analysis study

Mostafa Bahremand1, Ehsan Zereshki2, Behzad Karami Matin3

  • 1Cardiovascular Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Clinical Hypertension
|July 15, 2021
PubMed

Insights

Hypertension (HTN) shows a modest association with coronary artery ectasia (CAE) in unadjusted analyses. However, adjusted results suggest HTN has a minimal impact on CAE risk, highlighting the need for further research.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Epidemiology

Background:

  • Coronary artery ectasia (CAE) involves abnormal enlargement of coronary arteries.
  • Contradictory findings necessitate further investigation into CAE risk factors.
  • Hypertension (HTN) is a potential contributor to CAE.

Purpose of the Study:

  • To systematically review and meta-analyze the association between hypertension and coronary artery ectasia.
  • To evaluate the impact of HTN on the prevalence of CAE.

Main Methods:

  • Systematic search of Scopus, PubMed, and Science Direct databases.
  • Meta-analysis using a random-effects model to calculate pooled odds ratios (OR) and 95% confidence intervals (CIs).
  • Assessment of heterogeneity using I² index and subgroup/sensitivity analyses.

Main Results:

  • Forty studies comprising 3,263 cases and 7,784 controls were analyzed.
  • Unadjusted analysis showed an OR of 1.44 (95% CI, 1.24-1.68) for CAE in hypertensive individuals.
  • Adjusted analysis of nine articles (624 cases, 628 controls) yielded an OR of 1.03 (95% CI, 0.80-1.25) with significant heterogeneity.

Conclusions:

  • Hypertension alone minimally increases the risk of CAE (approximately 3% in adjusted analyses).
  • This finding underscores the importance of considering multiple risk factors in CAE.
  • Further research focusing on adjusted effects is recommended to confirm these associations.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
127
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
117
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
548
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
215
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
426